Development and Validation of New High Performance Liquid Chromatography Analytical Technique For Separation of Diclofenac Sodium and Lidocaine Hydrochloride From Ampoule Injection

In the current investigation, a number of chromatographic methods with the accurate, precise and specific criteria have been developed and validated for diclofenac sodium and lidocaine hydrochloride Commitment of their large quantities ampule of pharmaceutical dosage form. The High-Performance Liqui...

Full description

Bibliographic Details
Main Authors: Mohammed Ali Salih, Dlivan Fattah Aziz, Salar Ibrahim Ali
Format: Article
Language:English
Published: Sulaimani Polytechnic University 2020-06-01
Series:Kurdistan Journal of Applied Research
Subjects:
Online Access:http://www.kjar.spu.edu.iq/index.php/kjar/article/view/514
id doaj-cbe76e54273c4def8485d213cc9e83f1
record_format Article
spelling doaj-cbe76e54273c4def8485d213cc9e83f12020-11-25T03:51:29ZengSulaimani Polytechnic UniversityKurdistan Journal of Applied Research2411-76842411-77062020-06-015111512710.24017/science.2020.1.11514Development and Validation of New High Performance Liquid Chromatography Analytical Technique For Separation of Diclofenac Sodium and Lidocaine Hydrochloride From Ampoule InjectionMohammed Ali Salih0Dlivan Fattah Aziz1Salar Ibrahim Ali2Chemistry Department, College of Science, University of Sulaimani, Sulaimani. IraqCollege of Pharmacy, University of Sulaimani, Sulaimani, IraqNursing Department, Technical College of Health, Sulaimani Polytechnic University, Sulaimani, IraqIn the current investigation, a number of chromatographic methods with the accurate, precise and specific criteria have been developed and validated for diclofenac sodium and lidocaine hydrochloride Commitment of their large quantities ampule of pharmaceutical dosage form. The High-Performance Liquid Chromatography (HPLC) system was performed at 25 ° C; with appropriate chromatographic isolation accomplished through the use of Waters Symmetry SB-C7 column with a mobile phase containing 0.1 M sodium acetate and methanol (40:60) (v/v). During development the portable stage was delivered at a stream rate of 1 mL/min, the wavelength was adjusted at 254 nm. First of all, the retention times for diclofenac sodium and lidocaine HCl were about 4.1 and 10.8 min accordingly. A performance and technical demonstration of the suggested Revers phase-HPLC method has been numerically challenged with support to process appropriateness, verticality, scales, simplicity, repeatability, sensitivity, stability, discovery and limits of quantification. In addition, the calibration curves for diclofenac sodium active pharmaceutical ingredient (API) with linear regressions > 0,999895 obtained linear in the distances 1870-5600 μg / mL. Moreover, for determining of lidocaine HCl drug, a range of 500 - 1500 μg/mL of working standard was used, the result showed for lidocain HCl that a linear curve with correlation coefficients of > 0.99980. Finally, the both drugs were isolated and resolute with selective and stable characteristics by the proposed technique. In the conclusion, successful validation of the HPLC approach has been demonstrated with high precision and accuracy for the assessment of both the mixed dosage form type of both diclofenac sodium and lidocaine HCl.http://www.kjar.spu.edu.iq/index.php/kjar/article/view/514diclofenac sodium, hcl lidocaine, reverse phase higher performance chrmomatography, simultaneous estimation
collection DOAJ
language English
format Article
sources DOAJ
author Mohammed Ali Salih
Dlivan Fattah Aziz
Salar Ibrahim Ali
spellingShingle Mohammed Ali Salih
Dlivan Fattah Aziz
Salar Ibrahim Ali
Development and Validation of New High Performance Liquid Chromatography Analytical Technique For Separation of Diclofenac Sodium and Lidocaine Hydrochloride From Ampoule Injection
Kurdistan Journal of Applied Research
diclofenac sodium, hcl lidocaine, reverse phase higher performance chrmomatography, simultaneous estimation
author_facet Mohammed Ali Salih
Dlivan Fattah Aziz
Salar Ibrahim Ali
author_sort Mohammed Ali Salih
title Development and Validation of New High Performance Liquid Chromatography Analytical Technique For Separation of Diclofenac Sodium and Lidocaine Hydrochloride From Ampoule Injection
title_short Development and Validation of New High Performance Liquid Chromatography Analytical Technique For Separation of Diclofenac Sodium and Lidocaine Hydrochloride From Ampoule Injection
title_full Development and Validation of New High Performance Liquid Chromatography Analytical Technique For Separation of Diclofenac Sodium and Lidocaine Hydrochloride From Ampoule Injection
title_fullStr Development and Validation of New High Performance Liquid Chromatography Analytical Technique For Separation of Diclofenac Sodium and Lidocaine Hydrochloride From Ampoule Injection
title_full_unstemmed Development and Validation of New High Performance Liquid Chromatography Analytical Technique For Separation of Diclofenac Sodium and Lidocaine Hydrochloride From Ampoule Injection
title_sort development and validation of new high performance liquid chromatography analytical technique for separation of diclofenac sodium and lidocaine hydrochloride from ampoule injection
publisher Sulaimani Polytechnic University
series Kurdistan Journal of Applied Research
issn 2411-7684
2411-7706
publishDate 2020-06-01
description In the current investigation, a number of chromatographic methods with the accurate, precise and specific criteria have been developed and validated for diclofenac sodium and lidocaine hydrochloride Commitment of their large quantities ampule of pharmaceutical dosage form. The High-Performance Liquid Chromatography (HPLC) system was performed at 25 ° C; with appropriate chromatographic isolation accomplished through the use of Waters Symmetry SB-C7 column with a mobile phase containing 0.1 M sodium acetate and methanol (40:60) (v/v). During development the portable stage was delivered at a stream rate of 1 mL/min, the wavelength was adjusted at 254 nm. First of all, the retention times for diclofenac sodium and lidocaine HCl were about 4.1 and 10.8 min accordingly. A performance and technical demonstration of the suggested Revers phase-HPLC method has been numerically challenged with support to process appropriateness, verticality, scales, simplicity, repeatability, sensitivity, stability, discovery and limits of quantification. In addition, the calibration curves for diclofenac sodium active pharmaceutical ingredient (API) with linear regressions > 0,999895 obtained linear in the distances 1870-5600 μg / mL. Moreover, for determining of lidocaine HCl drug, a range of 500 - 1500 μg/mL of working standard was used, the result showed for lidocain HCl that a linear curve with correlation coefficients of > 0.99980. Finally, the both drugs were isolated and resolute with selective and stable characteristics by the proposed technique. In the conclusion, successful validation of the HPLC approach has been demonstrated with high precision and accuracy for the assessment of both the mixed dosage form type of both diclofenac sodium and lidocaine HCl.
topic diclofenac sodium, hcl lidocaine, reverse phase higher performance chrmomatography, simultaneous estimation
url http://www.kjar.spu.edu.iq/index.php/kjar/article/view/514
work_keys_str_mv AT mohammedalisalih developmentandvalidationofnewhighperformanceliquidchromatographyanalyticaltechniqueforseparationofdiclofenacsodiumandlidocainehydrochloridefromampouleinjection
AT dlivanfattahaziz developmentandvalidationofnewhighperformanceliquidchromatographyanalyticaltechniqueforseparationofdiclofenacsodiumandlidocainehydrochloridefromampouleinjection
AT salaribrahimali developmentandvalidationofnewhighperformanceliquidchromatographyanalyticaltechniqueforseparationofdiclofenacsodiumandlidocainehydrochloridefromampouleinjection
_version_ 1724487425425670144